Abstract: A disease risk assessment apparatus (100) includes an assessment unit (1) for assessing the risk of developing dementia in a subject, based on the concentration of an amino acid in the blood of the subject. The amino acid includes at least one selected from the group consisting of histidine, phenylalanine, leucine, isoleucine, methionine, threonine, glycine, glutamine, lysine, asparagine, homocysteine, cystathionine, S-adenosylmethionine, and S-adenosylhomocysteine.

Abstract: An electronic device includes a housing, a first light guide plate, a second light guide plate, and a first adhesive member. A first hole in position to a first light-emitting source and a second hole in position to a second light-emitting source are formed on the housing. The first light guide plate has a first projection to be inserted into the first hole. The second light guide plate has a main-body plate portion to be superposed on the first light guide plate with the first projection penetrating therethrough and a second projection to be inserted into the second hole. The second light guide plate blocks out the light of the first light-emitting source with the main-body plate portion. The first adhesive member is inserted between the second light guide plate and the housing, and attaches the main-body plate portion to the housing.

Abstract: An electronic device includes a housing, a first light guide plate, a second light guide plate, and a first adhesive member. A first hole in position to a first light-emitting source and a second hole in position to a second light-emitting source are formed on the housing. The first light guide plate has a first projection to be inserted into the first hole. The second light guide plate has a main-body plate portion to be superposed on the first light guide plate with the first projection penetrating therethrough and a second projection to be inserted into the second hole. The second light guide plate blocks out the light of the first light-emitting source with the main-body plate portion. The first adhesive member is inserted between the second light guide plate and the housing, and attaches the main-body plate portion to the housing.

Abstract: A test method for diagnosing cerebral infarction, a test method for diagnosing the disease type of cerebral infarction, and a test method for predicting prognosis of cerebral infarction in a subject animal, which test methods comprise the step of measuring the amount of cartilage acidic protein 1 in a blood sample collected from the animal.

Abstract: Two genes implicated in arteriosclerotic diseases such as cerebral infarction were successfully identified by performing genome-wide correlation studies using SNPs by targeting the entire genome. Polymorphic mutations that can be used to examine the presence or absence of risk factors for arteriosclerotic diseases were successfully found on the genes. Subjects can be efficiently examined for the presence or absence of risk factors for arteriosclerotic diseases using the presence or absence of the polymorphic mutations as indicators. Furthermore, methods of screening for therapeutic agents for arteriosclerotic diseases are enabled by using expression or function of the genes as index.